These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26335214)

  • 1. Methylene blue, midodrine, and pseudoephedrine: a review of alternative agents for refractory hypotension in the intensive care unit.
    Van Berkel MA; Fuller LA; Alexandrov AW; Jones GM
    Crit Care Nurs Q; 2015; 38(4):345-58. PubMed ID: 26335214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral midodrine is effective for the treatment of hypotension associated with carotid artery stenting.
    Sharma S; Lardizabal JA; Bhambi B
    J Cardiovasc Pharmacol Ther; 2008 Jun; 13(2):94-7. PubMed ID: 18495904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock.
    Tchen S; Sullivan JB
    J Crit Care; 2020 Jun; 57():148-156. PubMed ID: 32145658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral midodrine treatment accelerates the liberation of intensive care unit patients from intravenous vasopressor infusions.
    Levine AR; Meyer MJ; Bittner EA; Berg S; Kalman R; Stanislaus AB; Ryan C; Ball SA; Eikermann M
    J Crit Care; 2013 Oct; 28(5):756-62. PubMed ID: 23845791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midodrine as adjunctive support for treatment of refractory hypotension in the intensive care unit: a multicenter, randomized, placebo controlled trial (the MIDAS trial).
    Anstey MH; Wibrow B; Thevathasan T; Roberts B; Chhangani K; Ng PY; Levine A; DiBiasio A; Sarge T; Eikermann M
    BMC Anesthesiol; 2017 Mar; 17(1):47. PubMed ID: 28327122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response to methylene blue in patients with severe hypotension during liver transplantation.
    Cheng SS; Berman GW; Merritt GR; Hendrickse A; Fiegel MJ; Teitelbaum I; Campsen J; Wachs M; Zimmerman M; Mandell MS
    J Clin Anesth; 2012 Jun; 24(4):324-8. PubMed ID: 22608589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of refractory hypotension with single-dose methylene blue after coronary artery bypass surgery.
    Yiu P; Robin J; Pattison CW
    J Thorac Cardiovasc Surg; 1999 Jul; 118(1):195-6. PubMed ID: 10384205
    [No Abstract]   [Full Text] [Related]  

  • 8. Methylene blue revisited: management of hypotension in a pediatric patient with bacterial endocarditis.
    Taylor K; Holtby H
    J Thorac Cardiovasc Surg; 2005 Aug; 130(2):566. PubMed ID: 16077431
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficacy and safety of midodrine in the treatment of dialysis-associated hypotension.
    Perazella MA
    Expert Opin Drug Saf; 2003 Jan; 2(1):37-47. PubMed ID: 12904123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoplegic syndrome--the role of methylene blue.
    Shanmugam G
    Eur J Cardiothorac Surg; 2005 Nov; 28(5):705-10. PubMed ID: 16143539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correction of severe hypotension by oral pseudoephedrine in a patient with idiopathic autonomic dysfunction.
    Patterson A; Bourgault AM; Crawford BR
    Am J Crit Care; 2008 Sep; 17(5):484, 481-3. PubMed ID: 18776006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose midodrine is not effective for treatment of persistent hypotension in the intensive care unit.
    Santer P; Eikermann M
    Intensive Care Med; 2021 Feb; 47(2):252-253. PubMed ID: 33416917
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of midodrine (Gutron) to treat permanent hypotension in a chronic hemodialysis patient.
    Montagnac R; Clavel P; Delhotal-Landes B; Flouvat B; Poulain S; Schllinger F
    Clin Nephrol; 2001 Aug; 56(2):162-8. PubMed ID: 11522094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midodrine in end-stage heart failure.
    Gonzalez-Cordero A; Ortiz-Troche S; Nieves-Rivera J; Mesa-Pabón M; Franqui-Rivera H
    BMJ Support Palliat Care; 2023 Oct; 13(e1):e86-e87. PubMed ID: 32581003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midodrine for the treatment of intradialytic hypotension.
    Lim PS; Yang CC; Li HP; Lim YT; Yeh CH
    Nephron; 1997; 77(3):279-83. PubMed ID: 9375820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Midodrine for Hypotension Outside of the Intensive Care Unit.
    Gutman LB; Wilson BJ
    J Popul Ther Clin Pharmacol; 2017 Aug; 24(3):e45-e50. PubMed ID: 28873293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of midodrine versus placebo on time to vasopressor discontinuation in patients with persistent hypotension in the intensive care unit (MIDAS): an international randomised clinical trial.
    Santer P; Anstey MH; Patrocínio MD; Wibrow B; Teja B; Shay D; Shaefi S; Parsons CS; Houle TT; Eikermann M;
    Intensive Care Med; 2020 Oct; 46(10):1884-1893. PubMed ID: 32885276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of sequential dialysis, mannitol and midodrine in managing children prone to dialysis failure.
    Hothi DK; Harvey E; Goia CM; Geary D
    Pediatr Nephrol; 2009 Aug; 24(8):1587-91. PubMed ID: 19294425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot, feasibility, randomised controlled trial of midodrine as adjunctive vasopressor for low-dose vasopressor-dependent hypotension in intensive care patients: The MAVERIC study.
    Costa-Pinto R; Yong ZT; Yanase F; Young C; Brown A; Udy A; Young PJ; Eastwood G; Bellomo R
    J Crit Care; 2022 Feb; 67():166-171. PubMed ID: 34801917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors predispose to hypotension refractory to norepinephrine but responsive to methylene blue.
    Sparicio D; Landoni G; Zangrillo A
    J Thorac Cardiovasc Surg; 2004 Feb; 127(2):608. PubMed ID: 14762391
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.